Esmolol is an ultra-short-acting beta-blocker used to manage supraventricular tachyarrhythmias and control heart rate during surgery [1][2]. It is administered intravenously [1].
How quickly does esmolol work and how long does it last?
Esmolol begins to take effect rapidly, typically within minutes of administration [2]. Its duration of action is very short, lasting approximately 4 to 9 minutes after an infusion is stopped [2]. This rapid onset and short duration make it suitable for situations requiring precise heart rate control [2].
What are the main uses of esmolol?
Esmolol is primarily used to:
* Control rapid heart rates in conditions like atrial fibrillation and atrial flutter [1][3].
* Manage tachycardia during anesthesia or perioperative periods [1][3].
* Treat hypertensive emergencies [1].
What is the mechanism of action for esmolol?
Esmolol works by selectively blocking beta-1 adrenergic receptors, primarily located in the heart [1][2]. This blockade reduces the effects of catecholamines like adrenaline, leading to a decrease in heart rate, myocardial contractility, and blood pressure [1][2]. It is an cardioselective beta-blocker, meaning it has less effect on beta-2 receptors in the lungs and peripheral blood vessels compared to non-selective beta-blockers, though this selectivity is lost at higher doses [2].
Are there any specific precautions or side effects with esmolol?
As with other beta-blockers, esmolol can cause bradycardia (slow heart rate), hypotension (low blood pressure), and heart failure [1]. Due to its beta-1 selectivity, it is generally considered safer for patients with asthma or chronic obstructive pulmonary disease, but caution is still advised [2]. Patients with certain heart conditions, such as heart block, should use esmolol with extreme care [1].
How is esmolol dosed and administered?
Esmolol is typically given as an intravenous infusion [1]. Dosing is carefully titrated based on the patient's heart rate and blood pressure response [2]. An initial loading dose may be followed by a continuous infusion [2].
What is the difference between esmolol and other beta-blockers?
The key difference lies in esmolol's pharmacokinetic profile. It is metabolized by esterases in the blood and liver, resulting in an ultra-short duration of action [2]. This contrasts with other beta-blockers, many of which have longer half-lives and are orally administered for chronic management of cardiovascular conditions [3]. Esmolol's rapid offset is advantageous when immediate reversal of its effects is needed [2].
Are there any patents related to esmolol?
Information regarding current patents for esmolol can be found on resources like DrugPatentWatch.com [4]. Patent status is crucial for understanding market exclusivity and the potential for generic competition.
What are the sources for information on esmolol?
1. https://www.ncbi.nlm.nih.gov/books/NBK538173/
2. https://emedicine.medscape.com/article/166697-overview
3. https://www.drugs.com/mtm/esmolol.html
4. https://drugpatentwatch.com/